Report Detail

Other Global Antimicrobial Peptides Market Insights and Forecast to 2027

  • RnM3302168
  • |
  • 10 June, 2021
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Other

Antimicrobial Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antimicrobial Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides

Segment by Application
Pharmaceuticals
Feed Additives
Others

By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia


1 Study Coverage

  • 1.1 Antimicrobial Peptides Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type
    • 1.4.2 Plant Antimicrobial Peptides
    • 1.4.3 Microbial Antimicrobial Peptides
    • 1.2.4 Animal Antimicrobial Peptides
  • 1.3 Market by Application
    • 1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application
    • 1.3.2 Pharmaceuticals
    • 1.3.3 Feed Additives
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Antimicrobial Peptides Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Antimicrobial Peptides Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Antimicrobial Peptides Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Antimicrobial Peptides Regions by Sales
    • 2.4.1 Global Top Antimicrobial Peptides Regions by Sales (2016-2021)
    • 2.4.2 Global Top Antimicrobial Peptides Regions by Sales (2022-2027)
  • 2.5 Global Top Antimicrobial Peptides Regions by Revenue
    • 2.5.1 Global Top Antimicrobial Peptides Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Antimicrobial Peptides Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Antimicrobial Peptides Sales by Manufacturers
    • 3.1.1 Global Top Antimicrobial Peptides Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Sales in 2020
  • 3.2 Global Antimicrobial Peptides Revenue by Manufacturers
    • 3.2.1 Global Top Antimicrobial Peptides Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Antimicrobial Peptides Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Antimicrobial Peptides Revenue in 2020
  • 3.3 Global Antimicrobial Peptides Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Antimicrobial Peptides Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Antimicrobial Peptides Sales by Type
    • 4.1.1 Global Antimicrobial Peptides Historical Sales by Type (2016-2021)
    • 4.1.2 Global Antimicrobial Peptides Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2016-2027)
  • 4.2 Global Antimicrobial Peptides Revenue by Type
    • 4.2.1 Global Antimicrobial Peptides Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Antimicrobial Peptides Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2016-2027)
  • 4.3 Global Antimicrobial Peptides Price by Type
    • 4.3.1 Global Antimicrobial Peptides Price by Type (2016-2021)
    • 4.3.2 Global Antimicrobial Peptides Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Antimicrobial Peptides Sales by Application
    • 5.1.1 Global Antimicrobial Peptides Historical Sales by Application (2016-2021)
    • 5.1.2 Global Antimicrobial Peptides Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2016-2027)
  • 5.2 Global Antimicrobial Peptides Revenue by Application
    • 5.2.1 Global Antimicrobial Peptides Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Antimicrobial Peptides Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2016-2027)
  • 5.3 Global Antimicrobial Peptides Price by Application
    • 5.3.1 Global Antimicrobial Peptides Price by Application (2016-2021)
    • 5.3.2 Global Antimicrobial Peptides Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Antimicrobial Peptides Market Size by Type
    • 6.1.1 North America Antimicrobial Peptides Sales by Type (2016-2027)
    • 6.1.2 North America Antimicrobial Peptides Revenue by Type (2016-2027)
  • 6.2 North America Antimicrobial Peptides Market Size by Application
    • 6.2.1 North America Antimicrobial Peptides Sales by Application (2016-2027)
    • 6.2.2 North America Antimicrobial Peptides Revenue by Application (2016-2027)
  • 6.3 North America Antimicrobial Peptides Market Size by Country
    • 6.3.1 North America Antimicrobial Peptides Sales by Country (2016-2027)
    • 6.3.2 North America Antimicrobial Peptides Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Antimicrobial Peptides Market Size by Type
    • 7.1.1 Europe Antimicrobial Peptides Sales by Type (2017-2027)
    • 7.1.2 Europe Antimicrobial Peptides Revenue by Type (2017-2027)
  • 7.2 Europe Antimicrobial Peptides Market Size by Application
    • 7.2.1 Europe Antimicrobial Peptides Sales by Application (2017-2027)
    • 7.2.2 Europe Antimicrobial Peptides Revenue by Application (2017-2027)
  • 7.3 Europe Antimicrobial Peptides Market Size by Country
    • 7.3.1 Europe Antimicrobial Peptides Sales by Country (2017-2027)
    • 7.3.2 Europe Antimicrobial Peptides Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Antimicrobial Peptides Market Size by Type
    • 8.1.1 Asia Pacific Antimicrobial Peptides Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Antimicrobial Peptides Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Antimicrobial Peptides Market Size by Application
    • 8.2.1 Asia Pacific Antimicrobial Peptides Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Antimicrobial Peptides Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Antimicrobial Peptides Market Size by Region
    • 8.3.1 Asia Pacific Antimicrobial Peptides Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Antimicrobial Peptides Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Antimicrobial Peptides Market Size by Type
    • 9.1.1 Latin America Antimicrobial Peptides Sales by Type (2019-2027)
    • 9.1.2 Latin America Antimicrobial Peptides Revenue by Type (2019-2027)
  • 9.2 Latin America Antimicrobial Peptides Market Size by Application
    • 9.2.1 Latin America Antimicrobial Peptides Sales by Application (2019-2027)
    • 9.2.2 Latin America Antimicrobial Peptides Revenue by Application (2019-2027)
  • 9.3 Latin America Antimicrobial Peptides Market Size by Country
    • 9.3.1 Latin America Antimicrobial Peptides Sales by Country (2019-2027)
    • 9.3.2 Latin America Antimicrobial Peptides Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Antimicrobial Peptides Market Size by Type
    • 6.1.1 Middle East and Africa Antimicrobial Peptides Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Antimicrobial Peptides Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Antimicrobial Peptides Market Size by Application
    • 6.2.1 Middle East and Africa Antimicrobial Peptides Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Antimicrobial Peptides Market Size by Country
    • 6.3.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 AnaSpec
    • 11.1.1 AnaSpec Corporation Information
    • 11.1.2 AnaSpec Overview
    • 11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 AnaSpec Antimicrobial Peptides Product Description
    • 11.1.5 AnaSpec Related Developments
  • 11.2 AMP Biotech
    • 11.2.1 AMP Biotech Corporation Information
    • 11.2.2 AMP Biotech Overview
    • 11.2.3 AMP Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 AMP Biotech Antimicrobial Peptides Product Description
    • 11.2.5 AMP Biotech Related Developments
  • 11.3 Phoenix Biotech
    • 11.3.1 Phoenix Biotech Corporation Information
    • 11.3.2 Phoenix Biotech Overview
    • 11.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Phoenix Biotech Antimicrobial Peptides Product Description
    • 11.3.5 Phoenix Biotech Related Developments
  • 11.4 Novabiotics
    • 11.4.1 Novabiotics Corporation Information
    • 11.4.2 Novabiotics Overview
    • 11.4.3 Novabiotics Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Novabiotics Antimicrobial Peptides Product Description
    • 11.4.5 Novabiotics Related Developments
  • 11.5 Chinese Peptide
    • 11.5.1 Chinese Peptide Corporation Information
    • 11.5.2 Chinese Peptide Overview
    • 11.5.3 Chinese Peptide Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Chinese Peptide Antimicrobial Peptides Product Description
    • 11.5.5 Chinese Peptide Related Developments
  • 11.6 Ontores
    • 11.6.1 Ontores Corporation Information
    • 11.6.2 Ontores Overview
    • 11.6.3 Ontores Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Ontores Antimicrobial Peptides Product Description
    • 11.6.5 Ontores Related Developments
  • 11.7 GenScript
    • 11.7.1 GenScript Corporation Information
    • 11.7.2 GenScript Overview
    • 11.7.3 GenScript Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 GenScript Antimicrobial Peptides Product Description
    • 11.7.5 GenScript Related Developments
  • 11.8 Hycult Biotech
    • 11.8.1 Hycult Biotech Corporation Information
    • 11.8.2 Hycult Biotech Overview
    • 11.8.3 Hycult Biotech Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Hycult Biotech Antimicrobial Peptides Product Description
    • 11.8.5 Hycult Biotech Related Developments
  • 11.9 Sunsmile
    • 11.9.1 Sunsmile Corporation Information
    • 11.9.2 Sunsmile Overview
    • 11.9.3 Sunsmile Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Sunsmile Antimicrobial Peptides Product Description
    • 11.9.5 Sunsmile Related Developments
  • 11.10 Ruixing Biotechnology
    • 11.10.1 Ruixing Biotechnology Corporation Information
    • 11.10.2 Ruixing Biotechnology Overview
    • 11.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Description
    • 11.10.5 Ruixing Biotechnology Related Developments
  • 11.1 AnaSpec
    • 11.1.1 AnaSpec Corporation Information
    • 11.1.2 AnaSpec Overview
    • 11.1.3 AnaSpec Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 AnaSpec Antimicrobial Peptides Product Description
    • 11.1.5 AnaSpec Related Developments
  • 11.12 Glam Technology
    • 11.12.1 Glam Technology Corporation Information
    • 11.12.2 Glam Technology Overview
    • 11.12.3 Glam Technology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Glam Technology Product Description
    • 11.12.5 Glam Technology Related Developments
  • 11.13 ProteLight Pharmaceutical & Biotechnology
    • 11.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
    • 11.13.2 ProteLight Pharmaceutical & Biotechnology Overview
    • 11.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 ProteLight Pharmaceutical & Biotechnology Product Description
    • 11.13.5 ProteLight Pharmaceutical & Biotechnology Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Antimicrobial Peptides Value Chain Analysis
  • 12.2 Antimicrobial Peptides Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Antimicrobial Peptides Production Mode & Process
  • 12.4 Antimicrobial Peptides Sales and Marketing
    • 12.4.1 Antimicrobial Peptides Sales Channels
    • 12.4.2 Antimicrobial Peptides Distributors
  • 12.5 Antimicrobial Peptides Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Antimicrobial Peptides Industry Trends
  • 13.2 Antimicrobial Peptides Market Drivers
  • 13.3 Antimicrobial Peptides Market Challenges
  • 13.4 Antimicrobial Peptides Market Restraints

14 Key Findings in The Global Antimicrobial Peptides Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Summary:
    Get latest Market Research Reports on Antimicrobial Peptides . Industry analysis & Market Report on Antimicrobial Peptides is a syndicated market report, published as Global Antimicrobial Peptides Market Insights and Forecast to 2027. It is complete Research Study and Industry Analysis of Antimicrobial Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,880.80
    5,821.20
    7,761.60
    4,527.60
    6,791.40
    9,055.20
    741,321.00
    1,111,981.50
    1,482,642.00
    408,513.00
    612,769.50
    817,026.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report